Page 22 - Serum Institute Of India

The story behind the rise of Serum Institute, world's vaccine factory

Today, SII sells about 1.5 billion vaccine doses every year to 170 countries and is the largest producer of vaccines globally by number of doses

Serum Institute gets SEC thumbs up; Bharat Biotech proposal being discussed

US giant Pfizer did not come to present its case on Friday before the Subject Expert Committee

Panel clears Covid-19 vaccine manufactured by Serum Institute: Reports

The Serum Institute of India (SII), the local maker of the vaccine called Covishield, has stockpiled about 50 million doses of the vaccine, enough for 25 million people, said its CEO last week

Drug controller hints vaccine approval will make it a 'happy new year'

V G Somani's statement comes even as subject expert committee is set to meet on Jan 1 to consider three emergency-use authorisation applications

India's Covid vaccine hope rolls over to 2021; panel to meet again on Jan 1

Sources close to the development said the expert committee sought more information from Serum Institute regarding the Oxford-AstraZeneca vaccine

Drug regulator to meet again on Jan 1 to discuss AstraZeneca vaccine

India is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany's BioNTech, and by India's Bharat Biotech

India drug regulator meets to discuss AstraZeneca vaccine: Report

SII, the world's biggest producer of vaccines, has already stockpiled about 50 million doses, enough for 25 million people

UK nod to Astra vaccine positive news, waiting for India's approval: SII

SII termed the approval for Oxford-AstraZeneca Covid-19 vaccine in the UK as encouraging news

Serum Institute's vaccine to be considered for emergency approval today

The development came after the UK became the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca

Health Minister inaugurates India's first pneumococcal conjugate vaccine

Union Health Minister Dr Harsh Vardhan On Monday inaugurated India's first pneumococcal conjugate vaccine "Pneumosil", which has been developed by the Serum Institute of India

Nod for Covid vaccine in the next few days: Serum Institute's Poonawalla

SII has stockpiled 40-50 mn doses and is adding more every week. Most of these will come to India, as exporting would require fulfilling WHO's pre-qualification procedures

Vardhan launches indigenously developed pneumococcal vaccine 'Pneumosil'

Pneumosil was found to be safe and effective in the prevention of pneumonia and based on which Pneumosil has been licensed by the Drugs Controller General of India in July 2020

India's first fully indigenous pneumococcal vaccine launched

Serum Institute of India announced the launch of India's first indigenously developed pneumococcal vaccine -- Pneumosil

We are researching two candidates for Covid vaccines: Serum Institute CEO

In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity

Faltering health infra gets a shot in the arm as vaccine roll-out nears

As an extraordinary year is drawing to a close, a seven-part series looks at the key areas that are on the cusp of dramatic changes

Bharat Biotech halfway through in one of country's largest phase-3 trials

Pfizer yet to submit data to regulator while Serum Institute has provided all additional information for emergency use authorisation

India likely to approve AstraZeneca vaccine by next week: Sources

This could be the first country to give the regulatory green light for the British drugmaker's vaccine as the British medicine regulator continues to examine data from the trials

India requires Rs 80,000 cr for vaccine distribution next year: Serum

Serum Institute of India said that the country would require a massive funding of Rs 80,000 crore for distribution of the Covid vaccine for the next one year

Global partnership COVAX secures 2 billion coronavirus vaccine doses

Global vaccine partnership COVAX has lined up almost two billion doses of existing and candidate Covid-19 vaccines for use worldwide

Serum Institute to seek nod for two full-dose regimen of Covishield

Suresh Jadhav, executive director of the Pune-based firm, said on Friday Serum was seeking approval from the Drug Controller General of India (DCGI) for the two-full dose regimen